Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DOPAMINERGIC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
DOPAMINERGIC is a concept in neurodegeneration research. Key relationships include: co discussed, causes, regulates. Associated with NEURODEGENERATION, PARKINSON, PARKINSON'S. Connected to 145 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | DOPAMINERGIC |
| Key Genes/Proteins | ACHE, ACTB, AD, AIF1, AKT, Alpha-Synuclein |
| Related Diseases | aging, Alzheimer'S Disease |
Knowledge base pages for this entity
graph TD
DOPAMINERGIC["DOPAMINERGIC"]
DOPAMINERGIC -->|"causes"| NEURON["NEURON"]
DOPAMINERGIC -->|"causes"| NEURONS["NEURONS"]
DOPAMINERGIC -->|"causes"| SENESCENCE["SENESCENCE"]
DOPAMINERGIC -->|"causes"| PARKIN["PARKIN"]
DOPAMINERGIC -->|"causes"| PARKINSON["PARKINSON"]
DOPAMINERGIC -->|"causes"| PARKINSON_S["PARKINSON'S"]
DOPAMINERGIC -->|"causes"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
DOPAMINERGIC -->|"causes"| SUBSTANTIA_NIGRA["SUBSTANTIA NIGRA"]
DOPAMINERGIC -->|"regulates"| PI3K["PI3K"]
AKT["AKT"] -->|"regulates"| DOPAMINERGIC
ASTROCYTE["ASTROCYTE"] -->|"interacts"| DOPAMINERGIC
ASTROCYTES["ASTROCYTES"] -->|"interacts"| DOPAMINERGIC
COMPLEMENT["COMPLEMENT"] -->|"activates"| DOPAMINERGIC
APOPTOSIS["APOPTOSIS"] -->|"causes"| DOPAMINERGIC
AMPK["AMPK"] -->|"activates"| DOPAMINERGIC
AUTOPHAGY["AUTOPHAGY"] -->|"promotes"| DOPAMINERGIC| Target | Relation | Type | Str |
|---|---|---|---|
| MICROGLIA | expresses | cell_type | 0.70 |
| LRRK2 | associated_with | gene | 0.70 |
| JAK | inhibits | gene | 0.70 |
| NEURONS | enhances | cell_type | 0.70 |
| WNT | activates | gene | 0.70 |
| MOTOR NEURON | expresses | cell_type | 0.70 |
| PINK1 | activates | gene | 0.70 |
| TFEB | activates | gene | 0.70 |
| PINK1 | associated_with | gene | 0.70 |
| MICROGLIA | disrupts | cell_type | 0.70 |
| PLA2G6 | associated_with | gene | 0.70 |
| VPS35 | associated_with | gene | 0.70 |
| JAK | activates | gene | 0.70 |
| PARK7 | associated_with | gene | 0.70 |
| TFEB | causes | gene | 0.70 |
| MICROGLIA | causes | cell_type | 0.70 |
| FBXO7 | associated_with | gene | 0.70 |
| WNT | causes | gene | 0.70 |
| GBA | protects_against | gene | 0.70 |
| SYNJ1 | associated_with | gene | 0.70 |
| NEURONS | stabilizes | cell_type | 0.70 |
| TFEB | associated_with | gene | 0.70 |
| GLUTAMATERGIC | inhibits | cell_type | 0.70 |
| NEURONS | markers | cell_type | 0.70 |
| LRRK2 | inhibits | gene | 0.70 |
| HTR2A | regulates | gene | 0.70 |
| TREM2 | disrupts | gene | 0.70 |
| STING | expresses | gene | 0.70 |
| STING | associated_with | gene | 0.70 |
| DRD2 | activates | gene | 0.70 |
| SLC6A4 | regulates | gene | 0.70 |
| NOTCH | transports | gene | 0.70 |
| GBA | expresses | gene | 0.70 |
| NEURONS | disrupts | cell_type | 0.70 |
| NECROPTOSIS | protects_against | pathway | 0.70 |
| RAGE | interacts_with | gene | 0.70 |
| TNF | activates | gene | 0.70 |
| MICROGLIA | mediates | cell_type | 0.70 |
| NECROPTOSIS | activates | pathway | 0.70 |
| MLKL | activates | gene | 0.70 |
| PINK1 | interacts_with | gene | 0.70 |
| STING | activates | gene | 0.70 |
| DRD2 | inhibits | gene | 0.70 |
| SNCA | markers | gene | 0.70 |
| GLUTAMATERGIC | activates | cell_type | 0.70 |
| SNCA | activates | gene | 0.70 |
| DRD2 | regulates | gene | 0.70 |
| MAPT | activates | gene | 0.70 |
| PLP1 | activates | gene | 0.70 |
| GABAERGIC | activates | cell_type | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ATP13A2 | associated_with | gene | 0.70 |
| CHRNA7 | regulates | gene | 0.70 |
| BDNF | expresses | gene | 0.70 |
| ATG5 | mediates | gene | 0.70 |
| ACHE | regulates | gene | 0.70 |
| BDNF | markers | gene | 0.70 |
| COMT | regulates | gene | 0.70 |
| CYP46A1 | inhibits | gene | 0.70 |
| AQP4 | causes | gene | 0.65 |
| BECN1 | associated_with | gene | 0.65 |
| CASP1 | associated_with | gene | 0.65 |
| AIF1 | associated_with | gene | 0.65 |
| ATG7 | associated_with | gene | 0.65 |
| ATG5 | associated_with | gene | 0.65 |
| CYTOKINES | interacts_with | gene | 0.60 |
| PARKINSON | interacts_with | gene | 0.60 |
| CD4 | regulates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| HUNTINGTON | regulates | gene | 0.60 |
| PARKINSON | regulates | gene | 0.60 |
| TUBB3 | regulates | gene | 0.60 |
| NDUFA9 | regulates | gene | 0.60 |
| ASTROCYTES | interacts_with | cell_type | 0.60 |
| ASTROCYTE | interacts_with | gene | 0.60 |
| GCASE | causes | gene | 0.60 |
| NEURON | causes | gene | 0.60 |
| PLIN2 | causes | gene | 0.60 |
| GBA | causes | gene | 0.60 |
| AGING | causes | gene | 0.60 |
| SLC6A3 | regulates | gene | 0.60 |
| SNCA | inhibits | gene | 0.60 |
| TUBB | regulates | gene | 0.60 |
| ASTROCYTE | interacts_with | cell_type | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| TUBB4B | regulates | gene | 0.60 |
| GFP | associated_with | gene | 0.60 |
| SNCA | regulates | gene | 0.60 |
| SYNAPSE | regulates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| ACTB | associated_with | gene | 0.60 |
| ATG7 | associated_with | gene | 0.60 |
| SQSTM1 | inhibits | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| IL1B | inhibits | gene | 0.60 |
| UBIQUITIN | inhibits | gene | 0.60 |
| NLRP3 | inhibits | gene | 0.60 |
| NLR | inhibits | gene | 0.60 |
| GAPDH | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A | 0.790 | neurodegeneration | epigenetic reprogramming aging neurons |
| Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio | 0.740 | neuroscience | Circuit-level neural dynamics in neurode |
| Correcting Gut Microbial Dopamine Imbalance to Support Syste | 0.606 | neurodegeneration | What are the mechanisms by which gut mic |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Plasma ATN biomarkers across AD continuum in Chilean cohort | clinical | Alzheimer's disease | 0.950 | 0.00 | Chilean older adults (n=318) w | proposed | N/A |
| Tau depletion effects on neuronal development in primary cultures | exploratory | 0.900 | 0.00 | primary rodent neuronal cultur | proposed | N/A | |
| Differential GWAS of schizophrenia vs PTSD | exploratory | schizophrenia, post-traumatic | 0.900 | 0.00 | human patients - European ance | proposed | N/A |
| Tau depletion effects on neuronal development in primary cultures | exploratory | 0.900 | 0.00 | primary rodent neuronal cultur | proposed | N/A | |
| Creation and validation of 3xAD-ChAT-Cre mouse model | validation | Alzheimer's disease | 0.900 | 0.00 | 3xAD-ChAT-Cre transgenic mice | proposed | N/A |
| GTEx brain tissue expression analysis of MAPT/CRHR1 locus | exploratory | schizophrenia, post-traumatic | 0.850 | 0.00 | human brain tissue samples fro | proposed | N/A |
| Microtubule domain analysis in adult axons | exploratory | 0.800 | 0.00 | adult rodent axons | proposed | N/A | |
| Tau depletion effects on microtubule domains in adult axons | exploratory | 0.800 | 0.00 | adult rodent neurons | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders [PMID:41699128] | ["Bolsewig K", "Bellomo G", "Hok-A-Hin Y | Nature medicine | 2026 | 0 |
| Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by [PMID:39881147] | ["Bolsewig K", "Willemse E", "S\u00e1nch | Nature communications | 2025 | 0 |
| Characterization of Vps13b-mutant mice reveals neuroanatomical and behavioral ph [PMID:37573958] | ["Montillot C", "Skutunova E", "Ayushma" | Neurobiology of disease | 2023 | 0 |
| Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neu [PMID:36692274] | ["Motta C", "Assogna M", "Bonomi C", "Di | European journal of neurology | 2023 | 0 |
| Bi-allelic loss of function variants in SLC30A5 as cause of perinatal lethal car [PMID:33547425] | Lieberwirth JK, Joset P, Heinze A, Hents | European journal of human gene | 2021 | 0 |
| Environmental Regulation, Technological Innovation, and Export Competitiveness: [PMID:32102174] | Liu J, Xie J | International journal of envir | 2020 | 0 |
| Predicting Subjective Recovery from Lower Limb Surgery Using Consumer Wearables. [PMID:33442582] | Karas M, Marinsek N, Goldhahn J, Foschin | Digital biomarkers | 2020 | 0 |
| DOPA Decarboxylase Modulates Tau Toxicity. [PMID:28751068] | ["Kow R", "Sikkema C", "Wheeler J", "Wil | Biological psychiatry | 2018 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity